共 50 条
- [1] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin[J]. DIABETES CARE, 2007, 30 (11) : 2794 - 2799Riddle, MatthewFrias, JuanZhang, BeiMaier, HollyBrown, CarlLutz, KarenKolterman, Orville
- [2] Pramlintide improved glycemic control and reduced weight without increased hypoglycemia in patients with type 2 diabetes inadequately controlled with insulin glargine ± oral agents[J]. DIABETES, 2007, 56 : A143 - A144Riddle, MatthewBrown, CarlZhang, BeiMaier, HollyLutz, KarenFrias, JuanKolterman, Orville
- [3] Pramlintide improved glycemic control and reduced body weight in patients with type 2 diabetes treated with basal insulin (without mealtime insulin) and a thiazolidinedione[J]. DIABETES, 2007, 56 : A147 - A147Lorenzi, GayleFrias, JuanLutz, KarenKesty, NicoleZhang, BeiKolterman, Orville
- [4] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin[J]. DIABETES, 2008, 57 : A156 - A156Riddle, MatthewZhang, BeiMaier, HollyWilhelm, KenKolterman, Orville
- [5] Insulin Degludec Improved Glycemic Control without Increasing Hypoglycemia in Patients with Type 1 Diabetes[J]. DIABETES, 2014, 63 : A237 - A237Hamamoto, YoshiyukiHonjo, SachikoFujimoto, KantaTatsuoka, HisatoTokumoto, ShinsukeYamaguchi, RiekoShibayama, YuiOkamura, EmiWada, YoshiharuIkeda, HirokiKoshiyama, Hiroyuki
- [6] Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus?[J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (04): : 194 - 195Edelman, Steven V.
- [7] Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus?[J]. Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 194 - 195Steven V Edelman
- [8] Effect of pramlintide treatment on markers of cardiovascular risk in patients with type 2 diabetes using basal insulin[J]. DIABETOLOGIA, 2007, 50 : S514 - S514Lush, C.Zhang, B.Maggs, D.Darsow, T.Kolterman, O.
- [9] Pramlintide improved glycaemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin[J]. DIABETOLOGIA, 2008, 51 : S409 - S409Wilhelm, K.Riddle, M.Zhang, B.Maier, H.Kolterman, O.
- [10] Pramlintide, as an adjunct to basal insulin, reduced C-reactive protein, improved glycemic control, and led to weight loss in patients with type 2 diabetes[J]. DIABETES, 2007, 56 : A144 - A144Lush, CameronFrias, JuanZhang, BeiMaier, HollyKolterman, Orville